3-157414030-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001167912.2(VEPH1):c.757A>T(p.Ile253Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000109 in 1,613,376 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001167912.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VEPH1 | NM_001167912.2 | c.757A>T | p.Ile253Phe | missense_variant | 6/14 | ENST00000362010.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VEPH1 | ENST00000362010.7 | c.757A>T | p.Ile253Phe | missense_variant | 6/14 | 1 | NM_001167912.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152110Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000797 AC: 20AN: 250988Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135654
GnomAD4 exome AF: 0.000109 AC: 160AN: 1461266Hom.: 0 Cov.: 31 AF XY: 0.0000908 AC XY: 66AN XY: 726914
GnomAD4 genome AF: 0.000105 AC: 16AN: 152110Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74292
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.757A>T (p.I253F) alteration is located in exon 6 (coding exon 5) of the VEPH1 gene. This alteration results from a A to T substitution at nucleotide position 757, causing the isoleucine (I) at amino acid position 253 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at